In this article, the authors present their recent findings on drug-eluting, extended-wear contact lenses for glaucoma and discuss how these lenses may provide week-long IOP reduction with just one day of wear.
Dr Thomassen shares his personal experiences with the MFR2 IOL, including reasons why the MFR2 is his lens of preference, clinical findings from a real-life setting and considerations for future use.
In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.
The piezo-print microdosing delivers drugs in less than 80 milliseconds, beating the eye’s 100-millisecond reflex.
Exfoliative glaucoma can prove to be a particularly difficult disease for opthalmologists to manage. In this article, aspects of IOP-lowering therapy specific to this type of glaucoma are considered, as well as the range of treatments available and the potential advantages and challenges associated with each therapy.
In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.
In this article, the authors present their recent findings on drug-eluting, extended-wear contact lenses for glaucoma and discuss how these lenses may provide week-long IOP reduction with just one day of wear.
Take-home message: The various excimer ablation technologies have their pros and cons. Wavefront-guided ablations using aberrometry can provide the vast majority of patients with uncorrected vision of 20/20 with fewer postoperative visual symptoms.
In what is believed to be the largest reported series of spontaneous in-the-bag IOL dislocation, investigators analyze presenting characteristics and outcomes for 21 eyes with a capsular tension ring (CTR) and 84 eyes without one.
In this article, the authors discuss the benefits of nutritional supplementation in preventing AMD progression and consider which AREDS formulation is the most appropriate in smokers and non-smokers.
The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
In the case study discussed in this article, a patient who was treated for DME with a fluocinolone acetonide intravitreal implant reported improved vision-related quality of life and the ability to perform daily routines without problems. These benefits persisted 12-months after treatment.
The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Dr Mushtaq discusses one centre’s initial post-marketing experience with the fluocinolone acetonide intravitreal implant 0.19 mg. The implant demonstrated favourable outcomes and good patient acceptance.
The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
The authors present results from a retrospective chart review demonstrating effective management of exudative AMD using anti-VEGF/photodynamic combination therapy. Possible implications of these findings for clinical practice are also discussed.
Shortcomings in ablative procedures mean that new developments in refractive surgery are welcome. Arthur Cummings, MD, FRCSEd, reviews two new technologies that will increase patient satisfaction.
A glaucoma filtration device was equally effective in reducing IOP in pseudoexfoliative glaucoma and primary open-angle glaucoma patients, in a recent small study.
Microstent implantation had favorable and safe results in a group of patients with open-angle glaucoma in the DUETTE trial.
Capturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.
Capturing clinical images with the integration of electronic health records and smartphone applications can enhance practice efficiency and compliance.
Findings from basic science research elucidating the mechanisms of retinal ganglion cell axon degeneration, regeneration, and death have identified new therapeutic targets for glaucoma that are being investigated in preclinical and clinical studies.
Research presented in this article found anterior capsulotomy to be the main trigger for an increase of prostaglandins in aqueous humor immediately after laser-assisted cataract surgery. Optimised energy settings in combination with NSAIDs might therefore help reduce laser-induced miosis.
A small review recently found 28 different names for the procedure, and the chances are there are even more currently in use.
The title of this blog may have you answering in the affirmative -after all, working in medicine is all about the patients, right?
Glaucoma is a leading cause of blindness, a problem which is made even more serious by the fact that many patients do not notice any symptoms until it is too late to prevent permanent blindness.
A pupil expansion device is flexible, yet stable and can easily be inserted and removed for cataract surgery procedures.
Though anti-vascular endothelial growth factor therapy for diabetic macular edema showed impressive results in trials, clinicians have reported less success on their own.
Fellows, residents from around the world show promise for future of retinal research.